Patrizio Mazza

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

Massimo Federico, Stefano Luminari, Emilio Iannitto et al. · Journal of Clinical Oncology · 2009 · 272 citations · Full text

Medicine, Oncology, Pharmacology +12

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

Francesco Zaja, Michele Baccarani, Patrizio Mazza et al. · Blood · 2010 · 259 citations

Life Sciences, Immunology, Pharmacotherapy +7

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 215 citations · Full text

Medicine, Internal Medicine, Oncology +8

High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.

Angelo Michele Carella, A Congiu, Eugenia Gaozza et al. · Journal of Clinical Oncology · 1988 · 160 citations

Medicine, Oncology, Radiation Oncology +14

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

Pier Luigi Zinzani, Sergio Storti, Alfonso Zaccaria et al. · PubMed · 1999 · 153 citations

Medicine, Geriatric Medicine, Oncology +10